Market Research Logo

IVD in China, South Korea and Vietnam: 2018 Regional Report Bundle

Kalorama Information 2018 Regional IVD Market Bundle (IVD in China, The IVD Market in South Korea, The IVD Market in Vietnam)

This Kalorama Information (KI) Market Research Bundle is a combination of 3 complete KI in vitro diagnostics (IVD) reports, including IVD in China, The IVD Market in South Korea and The IVD Market in Vietnam.

The reports provide an overview of the IVD markets in China, South Korea and Vietnam. The revenue data provided give an overview of developments in the IVD industry in each respective country, presenting IVD revenues by extracted market segment for 2017 and 2022, which includes general chemistry, blood gas analysis, urinalysis, infectious disease immunoassays, other immunoassays, blood bank screening immunoassays, point-of-care (POC) glucose, POC other, ID/AST, microbiology molecular, HPV, CTC, other histology, and others.

The bundled reports provide China, South Korea and Vietnam in vitro diagnostic revenues by broad market segments for 2017 and 2022, comprising clinical chemistry, immunoassay, microbiology/molecular testing, POC, and histology. Also included in the report are trends influencing the industry and country-level data, including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.

This bundle represents the separate report PDFs, exactly as they were published, combined into one. A separate Table of Contents is included for each report in this bundle.


IVD IN CHINA
Chapter One: Executive Summary
Introduction
Figure 1-1: Market Drivers and Restraints: IVD Market in China
Scope and Methodology
Major Findings of the Report
IVD Market in China
Figure 1-2: China IVD Market, 2017 and 2022 ($ millions)
Chapter Two: China in Context
Overview
Figure 2-1 : China IVD Market vs. China Medical Device Market, 2017-2022
Figure 2-2 : China Market Dynamics
Population Trends
Table 2-1: Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
Figure 2-3 : Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
Figure 2-4: Total Number of Births in China by Year, 1990-2010 and Forecast 2020-2050
Figure 2-5: China Life Expectancy at Birth in Years, 2010-2050
Table 2-2 : Elderly Dependency Ratio in China and Other Select Countries, 2010 and 2050
Disease Demographics
Diabetes
Cancer
Table 2-6: Top 5 Cancers Affecting Chinese Population (ranked by total number of cases), 2010-2017
Cardiovascular Disease
Infectious Disease Threats
Hepatitis
HIV/AIDS
Tuberculosis
Chinese Economy
Figure 2-7: China GDP, GDP (PPP) and Health Spending, 1990-2015 (billions of $)
Chapter Three: Clinical Laboratory Structure in China
Clinical Laboratory Tests
Test Types
Table 3-1 : Types of IVD and Clinical Laboratory Tests, 2018
Venues for Test Usage
Figure 3-1: Utilization of Beds in Medical Institutions: China's Average Length of Stay is Increasing Slightly, 1985-2016
Figure 3-2: Number of Visits and Admissions to Hospital Institutions in China Annually, 2015
Urban vs. Rural IVD Market
Table 3-2: China In Vitro Diagnostic Reagent Sales by Urban/Rural Environment, 2017
Figure 3-3: Province-level Administrative Divisions of China
Table 3-3: Per Capita IVD Expenditures by China Province/Region, 2017 (Guangdon, Shangdon, Henan
Sichuan, Jiangsu, Hebei, Hunan, Anhui, Hubei, Zhejiang, Others)
Figure 3-4: China IVD Market by Province/Region
Chinese Healthcare Reform and Hospital Infrastructure
China Regulation and Medical Device Policy Challenges
Distribution in China
Medical Device Regulation Overview: China
Chapter Four: IVD Markets in China
Market Introduction and Summary
Table 4-1: China In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening, POC Glucose, POC Other, ID/AST, Microbiology Molecular, PT/INR Lab, Blood Group/Typing, Blood Type Molecular, HPV, CTC, Others)
Figure 4-1: China In Vitro Diagnostic Sales by Market Segment, 2017-2022 ($ millions)
Figure 4-2: China In Vitro Diagnostic Sales by Market Segment, 2017 Market Distribution (%)
Clinical Chemistry
Figure 4-3: China - Clinical Chemistry IVD Market, 2017-2022
Table 4-2: China - Clinical Chemistry IVD Market Distribution, 2017-2022 (%)
Figure 4-4: China - Clinical Chemistry IVD Market Value by Segment, 2017 vs. 2022
Point-of-Care (POC) Testing
Figure 4-5: China - Point-of-Care IVD Market, 2017-2022
Table 4-3: China - Point-of-Care IVD Market Distribution, 2017-2022 (%)
Figure 4-6: China - Point-of-Care IVD Market Value by Segment, 2017 vs. 2022
Immunoassays
Figure 4-7: China - Immunoassay IVD Market, 2017-2022
Table 4-4: China - Immunoassay IVD Market Distribution, 2017-2022 (%)
Figure 4-8: China - Immunoassay IVD Market Value by Segment, 2017 vs. 2022
Molecular Assays
Figure 4-9: China - Molecular Assay IVD Market, 2017-2022
Table 4-5: China - Molecular Assay IVD Market Distribution, 2017-2022 (%)
Figure 4-10: China - Molecular Assay IVD Market Value by Segment, 2017 vs. 2022
Table 4-6: HIV Statistics in China, 2016
Hematology
Figure 4-11: China - Hematology IVD Market, 2017-2022
Coagulation
Figure 4-12: China - Coagulation IVD Market, 2017-2022
Microbiology
Table 4-7: China Infectious Disease Classification Tier, December 2017 Impact
Figure 4-13: China - Microbiology IVD Market, 2017-2022
Table 4-8: China - Microbiology IVD Market Distribution, 2017-2022 (%)
Figure 4-14: China - Microbiology IVD Market Value by Segment, 2017 vs. 2022
Tests Used in Blood Banking
Figure 4-15: China - Blood Bank Test IVD Market, 2017-2022
Table 4-9: Prevalence of Transfusion-transmissible Infections in Blood Donations (Median, Interquartile range (IQR), by Income Group
Histology and Cytology
Figure 4-16: China - Histology/Cytology IVD Market, 2017-2022
Table 4-10: China - Histology/Cytology IVD Market Distribution, 2017-2022 (%)
Figure 4-17: China - Histology/Cytology IVD Market Value by Segment, 2017 vs. 2022
Prenatal and Genetic Test Services
Chapter Five: Company Activity in China
China IVD Market Participant Overview
Abbott Laboratories
Arkray
Becton, Dickinson & Co.
bioMérieux, Inc.
Bio-RAD Laboratories, Inc.
Danaher Corp.
Hologic, Inc.
Horiba Medical
Instrumentation Laboratory
Laboratory Corporation of America
Luminex Corporation
MedMira
Mindray Medical International, Ltd.
Myriad Genetics
Ortho Clinical Diagnostics
PerkinElmer
Promega Corporation
Qiagen N.V.
Roche
Shanghai Kehua Bio-engineering
Siemens AG
Sysmex Corp.
Thermo Fisher Scientific
Appendix: Sources of Information
IVD IN SOUTH KOREA
Chapter 1: Executive Summary
Industry Overview
Scope and Methodology
South Korea IVD Market Summary
Figure 1-1: South Korea In Vitro Diagnostic Sales by Market Segment, 2017-2022 ($ millions)
Chapter 2: South Korea Overview
Population
Table 2-1: Total Midyear Population by Broad Age Group: South Korea (million persons), 2010-2050
Figure 2-1: Total Midyear Population by Broad Age Group: South Korea (million persons), 2010-2050
Figure 2-2: Total Number of Births in South Korea by Year, 1990-2010 and Forecast 2020-2050
Figure 2-3: South Korea Life Expectancy at Birth in Years, 2010-2050
Health Indicators
General Health
Disease Profiles in South Korea
Table 2-2: Top 5 Cancers Affecting South Korean Population (ranked by total number of cases),
2008-2015
Economy and Health Spending
Figure 2-4: South Korea GDP, GDP (PPP) and Health Spending, 1990-2015 (billions of $)
Figure 2-5: South Korea Distribution of Income or Consumption by Quintile, 2007-2012
Health Infrastructure
Medical Facilities
Figure 2-6: South Korea JCI-Accredited Facilities, 2000-2018
Figure 2-7: Hospital Bed Density per 1,000 Population by Country, 2017 Estimates
Physicians
Figure 2-8: Physician Density per 1,000 Population by Country, 2017 Estimates
Medical Device Regulation
Table 2-3: Market Divers and Inhibitors for Entering South Korea's Medical Device Market
Chapter 3: IVD Markets in South Korea
Market Summary
Table 3-1: South Korea In Vitro Diagnostic Sales by Extracted Market Segment, 2017-2022 (General Chemistry, Blood Gas Analysis, Urinalysis, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening Immunoassays, POC Glucose, POC Other, ID/AST, Microbiology Molecular, HPV, CTC, Other Histology, Others, Total) ($ millions)
Figure 3-1: South Korea In Vitro Diagnostic Sales by Broad Market Segment, 2017-2022 (Histology, Microbiology, Clinical Chemistry, Immunoassay, POC, Other) ($ millions)
Figure 3-2: South Korea In Vitro Diagnostic Sales by Broad Market Segment, 2017 Market Distribution (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other) (%)
Clinical Chemistry
Figure 3-3: South Korea - Clinical Chemistry Market (General Chemistries, Blood Gas Analysis, Urinalysis), 2017-2022
Immunoassay
Figure 3-4: South Korea - Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2017-222
Microbiology/Molecular
Figure 3-5: South Korea Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular), 2017-2022
Point-of-Care
Figure 3-6: South Korea POC Market Value by Segment (Glucose, Infectious Disease, Other), 2017-2022
Histology
Figure 3-7: South Korea - Histology Market (HPV, CTC, Others), 2017-2022
IVD IN VIETNAM
Chapter 1: Executive Summary
Industry Overview
Scope and Methodology
Vietnam IVD Market Summary
Figure 1-1: Vietnam In Vitro Diagnostic Sales by Market Segment, 2017-2022 ($ millions)
Chapter 2: Vietnam Overview
Population
Table 2-1: Total Midyear Population by Broad Age Group: Vietnam (million persons), 2010-2050
Figure 2-1: Total Midyear Population by Broad Age Group: Vietnam (million persons), 2010-2050
Figure 2-2: Total Number of Births in Vietnam by Year, 1990-2010 and Forecast 2020-2050
Figure 2-3: Vietnam Life Expectancy at Birth in Years, 2010-2050
Health Indicators
General Health
Disease Profiles in Vietnam
Table 2-2: Top 5 Cancers Affecting Vietnamese Population (ranked by total number of cases), 2010-2015
Economy and Health Spending
Figure 2-4: Vietnam GDP, GDP (PPP) and Health Spending, 1990-2015 (billions of $)
Figure 2-5: Vietnam Distribution of Income or Consumption by Quintile, 2001-2014
Health Infrastructure
Medical Facilities
Figure 2-6: Hospital Bed Density per 1,000 Population by Country, 2017 Estimates
Physicians and Health Professionals
Figure 2-7: Physician Density per 1,000 Population by Country, 2017 Estimates
Medical Device Regulation
Table 2-3: Market Divers and Inhibitors for Entering Vietnam's Medical Device Market
Chapter 3: IVD Markets in Vietnam
Market Summary
Table 3-1: Vietnam In Vitro Diagnostic Sales by Extracted Market Segment, 2017-2022 (General Chemistry, Blood Gas Analysis, Urinalysis, Infectious Disease Immunoassays, Other Immunoassays, Blood Bank Screening Immunoassays, POC Glucose, POC Other, ID/AST, Microbiology Molecular, HPV, CTC, Other Histology, Others, Total) ($ millions)
Figure 3-1: Vietnam In Vitro Diagnostic Sales by Broad Market Segment, 2017 - 2022 (Histology, Microbiology, Clinical Chemistry, Immunoassay, POC, Other) ($ millions)
Figure 3-2: Vietnam In Vitro Diagnostic Sales by Broad Market Segment, 2017 Market Distribution (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other) (%)
Clinical Chemistry
Figure 3-3: Vietnam - Clinical Chemistry Market (General Chemistries, Blood Gas Analysis, Urinalysis),
2017 - 2022
Immunoassay
Figure 3-4: Vietnam - Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2017 - 2022
Microbiology/Molecular
Figure 3-5: Vietnam - Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular),
2017 - 2022
Point-of-Care
Figure 3-6: Vietnam - POC Market Value by Segment (Glucose, Infectious Disease, Others), 2017 - 2022
Histology
Figure 3-7: Vietnam - Histology Market (HPV, CTC, Others), 2017 - 2022

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report